Location, location, location - European access to new medicines is a national postcode lottery

EURACTIV - Europe has vast differences in the stages of a medicine's journey, from approval to pricing, and reimbursement, leading to significant delays and unequal patient access – often depending on a patient's residence. Read more

"The average time it takes for a new medicine to become available ranges from 126 days in Germany compared to 804 days in neighbouring Poland."